tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
XERS is currently covered by 2 analysts with an average price target of $9. This is a potential upside of $3.17 (2.97%) from yesterday's end of day stock price of $8.74.
Xeris Pharmaceuticals's activity chart (see below) currently has 40 price targets and 38 ratings on display. The stock rating distribution of XERS is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 62.56% with an average time for these price targets to be met of 440.53 days.
Highest price target for XERS is $10, Lowest price target is $8, average price target is $9.
Most recent stock forecast was given by from HC WAINWRIGHT on 02-Mar-2026. First documented stock forecast 16-Jul-2018.
Currently out of the existing stock ratings of XERS, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Aug-2025
$10
$2.31 (30.04%)
$10
Hold Since 07-Mar-2025
$8
$0.31 (4.03%)
Buy Since 18-Nov-2021
$9
$1.31 (17.04%)
$7
Buy Since 28-Mar-2024
$7
$-0.69 (-8.97%)
$6
Buy Since 29-Oct-2021
$8
$0.31 (4.03%)
$6.6
What is XERS (Xeris Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most bullish on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most reserved on XERS (Xeris Pharmaceuticals)?
